Travere Therapeutics (TVTX) EPS (2013 - 2026)
Travere Therapeutics (TVTX) EPS from Jun 30, 2013 to Mar 31, 2026. The TTM Travere Therapeutics (TVTX) EPS is -$0.23. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Travere Therapeutics (TVTX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -91.82% |
| 3 Years TTM | -39.17% |
| 5 Years TTM | -44.13% |
| All Time TTM | -20.08% |
Annual EPS change of Travere Therapeutics (TVTX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.40 | +42.88% |
| 2025 | -$0.28 | -92.36% |
| 2024 | -$3.68 | +207.31% |
| 2023 | -$1.20 | +16.86% |
| 2022 | -$1.02 | -64.47% |
| 2021 | -$2.88 | -11.13% |
| 2020 | -$3.24 | -4.58% |
| 2019 | -$3.40 | +36.98% |
| 2018 | -$2.48 | +63.53% |
| 2017 | -$1.52 | +20.05% |
| 2016 | -$1.26 | -139.30% |
| 2015 | $3.22 | -175.49% |
| 2014 | -$4.26 | +126.55% |
| 2013 | -$1.88 | -44.53% |
| 2012 | -$3.39 | N/A |
Comparison Travere Therapeutics (TVTX) five years EPS CAGR with competitors
Travere Therapeutics (TVTX) five years EPS CAGR is -44.12%.